Resilience: Clinical Trials

7 trials sponsored by Resilience, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting, 2 not yet recruiting. 4 Phase 3, 3 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 34Recruiting 3, Not yet recruiting 1
Not applicable3Recruiting 2, Not yet recruiting 1

Follow Resilience: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive Episodes
Edra PRO - Mood Disorder (Depressive Episodes)
Not applicableRecruitingResilience5942025-10-312026-05-01
Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC)
Remote symptoms moniotring - Head and Neck Squamous Cell Carcinoma HNSCC
Not applicableRecruitingCentre Henri Becquerel1922025-10-152025-12-30
A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer
multimodal Resilience© digital companion, Standard supportive care - Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Phase 3RecruitingGustave Roussy, Cancer Campus, Grand Paris1802025-09-092025-12-01
Randomized Controlled Trial Comparing Remote Patient Monitoring vs Standard Care in IBD Patients Initiating or Changing Advanced Therapy
GutyCare - IBD
Phase 3Not yet recruitingResilience1162025-06-012025-06-29
Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only
Resilience PRO - Cancer
Phase 3RecruitingResilience14582025-04-012026-04-03
CARE1 Pragmatic Clinical Trial
Nivolumab, Ipilimumab, Pembrolizumab - Metastatic Kidney Cancer, Metastatic Kidney Carcinoma
Phase 3RecruitingGustave Roussy, Cancer Campus, Grand Paris12502024-04-122025-01-16
Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma
ONCOLAXY Follow-up - Diffuse Large B Cell Lymphoma
Not applicableNot yet recruitingWeprom1602022-07-012022-04-05

Conditions studied

Breast Neoplasms (1)  ·  Carcinoma, Renal Cell (1)  ·  Kidney Neoplasms (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Mood Disorders (1)  ·  Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Interventions

Axitinib (1)  ·  Ipilimumab (1)  ·  Nivolumab (1)  ·  cabozantinib (1)  ·  lenvatinib (1)  ·  pembrolizumab (1)

Countries

France (6)  ·  Austria (1)  ·  Czechia (1)  ·  Germany (1)  ·  Netherlands (1)

Top investigators

Antoine Yrondi, MD, PhD (1)  ·  Sebastien Thureau, MD,PhD (1)

Results publications

PMID 42501860

NIH funding

2023 (1)